Synermore Biologics, China
Dr. Eric Tsao has served as the Chief Executive Officer of Synermore Biologics since the founding of the company in 2013. He has over 25 years of industrial experience with Johnson and Johnson, AstraZeneca, and Morningside Group. His areas of expertise include biological product development, process design, facility engineering, and operations. Dr. Tsao received his Ph.D. in Chemical Engineering from the University of Michigan.
Oral Presentation (In-Person)
